Tempest shareholders approve share issuance for asset purchase and extend rights plan

Tempest Therapeutics, Inc.

Approved issuance of 8,268,495 common shares for Asset Purchase Agreement with Erigen LLC and Factor Bioscience Inc.
Stockholders extended limited duration rights plan to October 10, 2026.
Amendment to 2023 Equity Incentive Plan approved, increasing share reserve by 1,410,000 shares.
Geoff Nichol elected Class I director with 1,003,845 votes for; broker non-votes 1,075,928.
Advisory say-on-pay approved with 816,856 votes for, 428,524 against.

item 3.03 item 5.02 item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-027203
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2026-01-28T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.389657+00:00
generated_at: 2026-05-16T06:59:22.280887+00:00
sec_items: ["3.03", "5.02", "5.07"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-027203
json_url: https://secwatch.observer/filing/0001193125-26-027203.json
markdown_url: https://secwatch.observer/filing/0001193125-26-027203.md
text_url: https://secwatch.observer/filing/0001193125-26-027203.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526027203/0001193125-26-027203-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526027203/d70064d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-027203

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.